Trade with your broker
Market capitalisation, EUR | 203,017.77 m |
EPS, EUR | 1.78 |
P/B ratio | 5.90 |
P/E ratio | 36.86 |
Dividend yield | 2.00% |
Revenue, EUR | 42,374.41 m |
Net income, EUR | 5,508.28 m |
Profit margin | 13.00% |
ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
Invesco NASDAQ-100 Equal Weight UCITS ETF Acc | 0.95% | Equity Technology Equal Weighted | 101 | 0.20% | - | - | A3EE27 | IE000L2SA8K5 |
First Trust Value Line® Dividend Index UCITS ETF Acc | 0.59% | Equity United States Dividend | 165 | 0.70% | 18 | +6.09% | A2PZMV | IE00BKVKW020 |
WisdomTree Megatrends UCITS ETF USD | 0.06% | Equity World Social/Environmental Innovation | 582 | 0.50% | 9 | - | A3EYCN | IE0000902GT6 |
Invesco EQQQ Nasdaq-100 UCITS ETF Acc | 0.28% | Equity United States Technology | 101 | 0.30% | 1,800 | +38.29% | A2N6RV | IE00BFZXGZ54 |
Invesco Nasdaq-100 ESG UCITS ETF Acc | 0.24% | Equity United States Technology Social/Environmental | 94 | 0.25% | 1,080 | +38.97% | A3CZGT | IE000COQKPO9 |
WisdomTree BioRevolution UCITS ETF USD Acc | 0.96% | Equity World Health Care Social/Environmental Biotech | 88 | 0.45% | 3 | -7.31% | A3CY21 | IE000O8KMPM1 |
iShares Nasdaq 100 UCITS ETF EUR Hedged Acc | 0.28% | Equity United States Technology | 101 | 0.36% | 587 | +31.95% | A2N34W | IE00BYVQ9F29 |
iShares Nasdaq 100 UCITS ETF (DE) | 0.28% | Equity United States Technology | 101 | 0.31% | 3,676 | +38.05% | A0F5UF | DE000A0F5UF5 |
L&G Global Thematic ESG Exclusions UCITS ETF USD Accumulating | 0.46% | Equity World Social/Environmental Innovation | 361 | 0.60% | 4 | +1.55% | A3DHPA | IE000VTOHNZ0 |
Xtrackers Nasdaq 100 UCITS ETF 1C | 0.28% | Equity United States Technology | 101 | 0.20% | 588 | +38.38% | A2QJU3 | IE00BMFKG444 |
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 3.65% | Equity United States Health Care Biotech | 222 | 0.35% | 33 | +1.12% | A2JDYM | IE00BDZVHG35 |
iShares Nasdaq US Biotechnology UCITS ETF | 3.65% | Equity United States Health Care Biotech | 222 | 0.35% | 414 | +0.89% | A2DWAW | IE00BYXG2H39 |
Invesco Nasdaq-100 UCITS ETF EUR Hedged | 0.28% | Equity United States Technology | 101 | 0.35% | 204 | +32.03% | A2DT9V | IE00BYVTMS52 |
Invesco Nasdaq-100 UCITS ETF CHF Hedged | 0.28% | Equity United States Technology | 101 | 0.35% | 233 | +26.89% | A2JAN0 | IE00BYVTMT69 |
Invesco Nasdaq-100 UCITS ETF GBP Hedged | 0.28% | Equity United States Technology | 101 | 0.35% | 233 | +37.10% | A2JNFA | IE00BYVTMW98 |
Deka Nasdaq-100® UCITS ETF | 0.28% | Equity United States Technology | 101 | 0.25% | 37 | - | ETFL62 | DE000ETFL623 |
L&G Pharma Breakthrough UCITS ETF | 3.27% | Equity World Health Care Innovation | 32 | 0.49% | 17 | -18.45% | A2H9XR | IE00BF0H7608 |
Invesco EQQQ Nasdaq-100 UCITS ETF | 0.28% | Equity United States Technology | 101 | 0.30% | 5,934 | +38.88% | 801498 | IE0032077012 |
iShares Nasdaq 100 UCITS ETF (Acc) | 0.28% | Equity United States Technology | 101 | 0.33% | 11,496 | +38.24% | A0YEDL | IE00B53SZB19 |
YTD | +8.16% |
1 month | +8.16% |
3 months | +7.29% |
6 months | +12.29% |
1 year | -3.99% |
3 years | +53.00% |
5 years | - |
Since inception (MAX) | +57.74% |
2023 | -3.39% |
2022 | +23.35% |
2021 | - |
2020 | - |
Volatility 1 year | 21.45% |
Volatility 3 years | 23.19% |
Volatility 5 years | - |
Return per risk 1 year | -0.19 |
Return per risk 3 years | 0.66 |
Return per risk 5 years | - |
Maximum drawdown 1 year | -17.63% |
Maximum drawdown 3 years | -19.35% |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -19.35% |